Newsletter
The Blink is SeedBlink's weekly newsletter covering European venture capital, startup funding rounds, and private market trends. New edition every Monday.
June 29, 2026
·
5
min read

The European private markets briefing you can't afford to miss. Deals, signals, and moves, decoded every Monday by SeedBlink.

We've watched this play out from inside the platform for six years and 200+ deals. The pattern repeats: capital concentrates, the bar for "ready" rises, and the founders who treat fundraising as a sprint keep losing to the ones who treat it as infrastructure.
That's the lens The Blink will bring every Monday. Five minutes, no padding, the reads we wish we'd had when we started.
If there's someone in your network who'd want this too, send them here: https://seedblink.com/newsletter
.png)

European venture funding grew 29% year over year in Q1 2026. Deal count fell 40%. Seed-stage activity dropped 44%. Late-stage funding nearly doubled. Rounds above €25M captured 79% of total deal value, up from 67% the year before. AI alone accounted for over 60% of deal value across the top ten rounds.
Full Q1 2026 market overview here.
That's not less capital. It's more concentrated capital, going to companies further along in their story.
For founders outside the mega-round bracket, the door isn't closed, it's just guarded differently. Investors aren't pulling back. They're just asking harder questions, earlier. The data room, the numbers, the answers, all of it has to hold up before the first call, not after.
That's an uncomfortable shift if you're used to pitching first and answering hard questions later.
The founders winning this market aren't the loudest or the fastest. They're the ones who showed up ready.

We've joined Allied for Startups, the network advocating for better startup policy across Europe, and we're bringing six years of private market experience into the conversation.
Most platforms in our space stay out of policy. We don't think that's the right call. Fragmentation isn't an abstract complaint when you've watched it up close: a founder setting up a new legal structure for every jurisdiction, an investor who can't syndicate across borders without three sets of lawyers.
We've spent years building infrastructure to absorb that friction. The next step is helping shape the rules that create it, which is part of why initiatives like EU-Inc matter to us.
Read more about our partnership.

France 🇫🇷
Alan raises €480M Series G
French health insurer Alan raised €480M at a €5.5bn valuation, one of Europe's largest non-AI rounds this year. This is a rare case of a profitable insurtech, that’s building a new category it calls "prevention insurance."
Germany 🇩🇪
Taktile raises $110M Series C
Berlin-based Taktile raised $110M led by Goldman Sachs to automate high-stakes financial decisions - a financial institution betting on a tool that takes over the regulated calls banks and insurers used to reserve for humans.
Netherlands 🇳🇱
Leyden Labs secures €40M
Dutch biotech Leyden Labs raised €40M for nasal sprays that block respiratory viruses at the point of entry. The Gates Foundation joined, backing access in low and middle-income countries.

The Case for Venture Capital in the Age of Superintelligence
If AI will eventually solve everything, what's left to fund? NFX reframes early-stage investing as society's "targeting system" for which problems AI gets pointed at first.
"AI-Powered" Isn't a Position
"AI-powered X" stops being a differentiator the moment five companies say it too. A playbook for building a brand that holds up when features can be copied overnight.
Late Stage Venture Is About Late Stage Founders
David George's case that growth-stage venture isn't about valuations, but about founders who can keep compounding ambition indefinitely. A clarifying read on what separates companies that scale from ones that plateau.
Written by

Denisa Lacatus
Communication and Content Specialist
TABLE OF CONTENT
Share this article